The endothelial cell protein C receptor - Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors

被引:96
作者
Regan, LM
StearnsKurosawa, DJ
Kurosawa, S
Mollica, J
Fukudome, K
Esmon, CT
机构
[1] UNIV OKLAHOMA,HLTH SCI CTR,OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,DEPT BIOCHEM,OKLAHOMA CITY,OK 73104
[2] UNIV OKLAHOMA,HLTH SCI CTR,OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,DEPT MOL BIOL,OKLAHOMA CITY,OK 73104
[3] HOWARD HUGHES MED INST,OKLAHOMA CITY,OK 73104
关键词
D O I
10.1074/jbc.271.29.17499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A soluble form of the endothelial cell protein C receptor (EPCR) was analyzed for the ability to modulate the functional properties of protein C and activated protein C (APC). in a plasma clotting system initiated with factor Xa, EPCR blocked the anticoagulant activity of APC in a dose-dependent fashion. EPCR had no influence on clotting in the absence of APC. Consistent with the plasma results, EPCR slowed the proteolytic inactivation of factor Va by slowing both of the key proteolytic cleavages in the heavy chain of factor Va. EPCR did not prevent protein C activation by the soluble thrombin-thrombomodulin complex, did not alter the inactivation of APC by alpha(1)-antitrypsin or protein C inhibitor, and did not influence the kinetics of peptide paranitroanilide substrate cleavage significantly. We conclude that EPCR binds to an exosite on APC that selectively modulates the enzyme specificity in a manner reminiscent of the influence of thrombomodulin on thrombin.
引用
收藏
页码:17499 / 17503
页数:5
相关论文
共 35 条
[1]   SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES [J].
BARENHOLZ, Y ;
GIBBES, D ;
LITMAN, BJ ;
GOLL, J ;
THOMPSON, TE ;
CARLSON, FD .
BIOCHEMISTRY, 1977, 16 (12) :2806-2810
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM [J].
DAHLBACK, B .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :923-927
[4]  
DITTMAN WA, 1990, BLOOD, V75, P329
[5]   AN UPDATE ON CLINICAL AND BASIC ASPECTS OF THE PROTEIN-C ANTICOAGULANT PATHWAY [J].
ESMON, CT ;
SCHWARZ, HP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1995, 5 (04) :141-148
[6]  
ESMON CT, 1993, METHOD ENZYMOL, V222, P359
[7]  
ESMON CT, 1979, J BIOL CHEM, V254, P964
[8]  
ESMON CT, 1982, J BIOL CHEM, V257, P7944
[9]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743
[10]  
ESMON NL, 1983, J BIOL CHEM, V258, P2238